Chronic obstructive pulmonary disease (COPD)
612 results
301 - 400
Short-acting beta2-agonists for chronic obstructive pulmonary disease 
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
Low-dose oral = high-dose IV steroids for initial treatment of acute COPD exacerbation- Inhaled steroids only decrease COPD exacerbations slightly
- Sputum purulence and CRP predict poor prognosis with COPD exacerbation
- Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care
- Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease
- Methylxanthines for exacerbations of chronic obstructive pulmonary disease
- Pulmonary rehabilitation for chronic obstructive pulmonary disease
- Oral corticosteroids for stable chronic obstructive pulmonary disease
- N-acetylcysteine in chronic bronchitis or COPD exacerbations
- Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
- Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
- Water‐based exercise training for chronic obstructive pulmonary disease
- Anticholinergics of greater benefit in COPD treatment
- Early outpatient follow-up linked with fewer readmissions for COPD patients
- No change in duration of mechanical ventilation with acetazolamide for COPD patients with metabolic alkalosis
- Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
- Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
- Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease
- Statins versus placebo for people with chronic obstructive pulmonary disease: Cochrane systematic review
- LABA+LAMA+ICS associated with greater decline in all-cause mortality than LABA+LAMA in patients with severe COPD (IMPACT)
- High-efficiency air cleaners decrease exacerbations and the use of rescue medication in former smokers with COPD
- Clarithromycin associated with cardiovascular events
- Risk of serious pneumonia in COPD patients using inhaled corticosteroids
- Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
- Tiotropium versus long‐acting beta‐agonists for stable chronic obstructive pulmonary disease
- Chronic non‐invasive ventilation for chronic obstructive pulmonary disease
- Domiciliary oxygen in chronic obstructive pulmonary disease
- Vitamin D for the management of chronic obstructive pulmonary disease
- Oxygen therapy in the pre‐hospital setting for acute exacerbations of chronic obstructive pulmonary disease
- One year of once-daily doxycycline does not reduce exacerbation frequency in adults with moderate to severe COPD
- Tiotropium mist associated with mortality in COPD treatment
- Guidelines for the management of COPD
- Proton pump inhibitors for chronic obstructive pulmonary disease
- The effect of adding inhaled corticosteroids to tiotropium and long-acting beta 2 -agonists for chronic obstructive pulmonary disease: Cochrane systematic review
- Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease
- Inhaled budesonide for COPD not associated with pneumonia
- Better outcomes with noninvasive ventilation for hospitalized COPD patients
- Long-acting beta 2 -agonists for chronic obstructive pulmonary disease: Cochrane systematic review
- Computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease
- List of abbreviations
- Tiotropium not associated with increase cardiovascular risk in patients with COPD
- Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest
- Digital interventions for the management of chronic obstructive pulmonary disease
- Short-term ambulatory oxygen for chronic obstructive pulmonary disease
- Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition: a mixed methods review
- Indacaterol, a once‐daily beta2‐agonist, versus twice‐daily beta2‐agonists or placebo for chronic obstructive pulmonary disease
- Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease
- Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
- Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease: Cochrane systematic review
- Non‐invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease
- Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease
- Home care by outreach nursing for chronic obstructive pulmonary disease
- Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
- Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
- Combination inhaled steroid and long‐acting beta2‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
- Hospital at home for acute exacerbations of chronic obstructive pulmonary disease
- Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease
- Tiotropium for stable chronic obstructive pulmonary disease
- LABA + glycopyrronium reduces exacerbations slightly more than LABA + steroid
- Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
- Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive pulmonary disease
- Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Symptomatic oxygen for chronic obstructive pulmonary disease
- Telehealthcare for chronic obstructive pulmonary disease
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
- Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
- Tiotropium via Soft Mist Inhaler increases all-cause mortality in COPD
- Oxygen therapy during exercise training in chronic obstructive pulmonary disease
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Breathing exercises for chronic obstructive pulmonary disease: Cochrane systematic review
- Smoking cessation for chronic obstructive pulmonary disease
- Singing for adults with chronic obstructive pulmonary disease
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
- Inhaled corticosteroids increase pneumonia risk in stable COPD
- Inhaled anticholinergics associated with increased risk of CVD in COPD
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
- C-reactive protein guidance safely reduces antibiotic use in patients with acute exacerbation of COPD (NNT = 5)
- Physician assessment of COPD doesn't match spirometry results
- Pulmonary rehabilitation for chronic obstructive pulmonary disease
- DECAF score provides accurate prognosis for patients with acute exacerbation of COPD
- Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
- Tiotropium for stable chronic obstructive pulmonary disease
- Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease: Cochrane systematic review
- Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
- Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
- 3-in-1 inhaler for chronic obstructive pulmonary disease may provide better outcomes than multiple individual inhalers (SKOPOS-MAZI)